Woodline Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$212M Buy
230,474
+17,612
+8% +$17.9M 0.8% 12
2025
Q4
$229M Sell
212,862
-72,099
-25% -$68.9M 0.89% 12
2025
Q3
$217M Buy
284,961
+182,504
+178% +$136M 1.02% 7
2025
Q2
$79.9M Sell
102,457
-54,840
-35% -$42.6M 0.42% 40
2025
Q1
$130M Buy
157,297
+55,488
+55% +$46.2M 0.84% 10
2024
Q4
$78.6M Sell
101,809
-12,618
-11% -$10.4M 0.53% 30
2024
Q3
$101M Sell
114,427
-170,162
-60% -$153M 0.85% 18
2024
Q2
$258M Sell
284,589
-33,235
-10% -$26.6M 2.46% 1
2024
Q1
$247M Buy
317,824
+753
+0.2% +$536K 2.28% 1
2023
Q4
$185M Buy
317,071
+45,071
+17% +$26.3M 2.01% 2
2023
Q3
$146M Sell
272,000
-22,853
-8% -$11.8M 1.71% 4
2023
Q2
$138M Buy
294,853
+187,624
+175% +$78.7M 1.64% 4
2023
Q1
$36.8M Hold
107,229
0.5% 49
2022
Q4
$39.2M Sell
107,229
-157,870
-60% -$56M 0.52% 38
2022
Q3
$85.7M Sell
265,099
-230,904
-47% -$73.2M 1.2% 5
2022
Q2
$161M Buy
496,003
+373,668
+305% +$112M 2.48% 2
2022
Q1
$35M Sell
122,335
-264,966
-68% -$68.2M 0.57% 42
2021
Q4
$107M Buy
387,301
+71,198
+23% +$18M 1.53% 5
2021
Q3
$73M Buy
316,103
+158,412
+100% +$39.1M 1.19% 11
2021
Q2
$36.2M Buy
157,691
+42,045
+36% +$8.45M 0.67% 36
2021
Q1
$21.6M Sell
115,646
-294,204
-72% -$57.5M 0.48% 65
2020
Q4
$69.2M Buy
409,850
+341,943
+504% +$51.1M 1.83% 8
2020
Q3
$10.1M Sell
67,907
-195,122
-74% -$30.2M 0.33% 85
2020
Q2
$43.2M Buy
263,029
+52,636
+25% +$8.08M 1.71% 16
2020
Q1
$29.2M Sell
210,393
-10,773
-5% -$1.48M 2.09% 11
2019
Q4
$29.1M Buy
+221,166
New +$25.6M 1.19% 31

Other funds holding LLY

Woodline Partners's LLY Position: Q1 2026 in Review

Woodline Partners increased its Eli Lilly (LLY) stake by 8.3% in Q1 2026, buying an estimated $17.9M and bringing the position to 230,474 shares worth $212M. The position accounts for 0.8% of the portfolio, ranked #12.

Woodline Partners first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $258M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Woodline Partners held 230,474 shares of Eli Lilly worth $212M as of Q1 2026.
  • Woodline Partners bought 17,612 Eli Lilly shares in Q1 2026, an estimated $17.9M.
  • Eli Lilly made up 0.8% of Woodline Partners's portfolio in Q1 2026, its #12 holding.
  • Woodline Partners first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • Woodline Partners's Eli Lilly position peaked at $258M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.